{
  "id": 1837861,
  "title": "India issues strict curbs, oversight on stem cell therapy for critical limb ischemia and chronic wounds",
  "url": "https://urgent.news/2026/08/19/india-issues-strict-curbs-oversight-on-stem-cell-therapy-for-critical",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-19T00:30:24.000Z",
  "source": {
    "name": "Live Mint",
    "slug": "live-mint",
    "url": "https://www.livemint.com/news/india/strict-curbs-oversight-stem-cell-therapy-critical-limb-ischemia-chronic-wounds-clinical-benefits-encouraging-innovation-11786961251361.html"
  },
  "original_language": "en",
  "account": "New Delhi: In a significant move, the Indian government has released strict guidelines to regulate the use of stem cell therapy for microvascular conditions like critical limb ischemia and chronic wounds. According to two senior officials familiar with the matter, the therapy will no longer be administered routinely in clinical settings, but will be permitted only within authorized research trials.\n\nThe decision comes from the Union Ministry of Health and has been backed by documents reviewed by Mint. Priyanka Sharma, a journalist at Mint specializing in the Union Ministry of Health and the pharmaceutical industry, reported on the development. With a background in journalism and public health, Sharma has provided clear and honest news on important health topics affecting the entire country.\n\nSharma's educational credentials include a journalism degree from the Indian Institute of Mass Communication (IIMC) and specialized training in public health from the Public Health Foundation of India. Prior to her current role at Mint, she worked with India Today, The Pioneer, and ANI, and served as a lead consultant for the National Health Authority. Based in New Delhi, Sharma is an avid traveler who enjoys the mountains and regional cuisines, particularly South Indian food.",
  "summary": "The health ministry said there has been “rampant use of this experimental therapy despite limited knowledge of its safety and efficacy” and little evidence to show any clinical benefits.",
  "key_points": [
    "Indian government issues strict guidelines for stem cell therapy regulation.",
    "Therapy limited to authorized research trials, not routine clinical use.",
    "Guidelines backed by Union Ministry of Health and Mint reports."
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}